Trustmark National Bank Trust Department’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.91M | Buy |
4,246
+22
| +0.5% | +$22.3K | 0.25% | 78 |
|
|
2025
Q4 | $4.54M | Buy |
4,224
+500
| +13% | +$478K | 0.29% | 70 |
|
|
2025
Q3 | $2.84M | Sell |
3,724
-129
| -3% | -$96K | 0.18% | 93 |
|
|
2025
Q2 | $3M | Buy |
3,853
+176
| +5% | +$137K | 0.21% | 93 |
|
|
2025
Q1 | $3.04M | Buy |
3,677
+308
| +9% | +$256K | 0.23% | 89 |
|
|
2024
Q4 | $2.6M | Sell |
3,369
-195
| -5% | -$161K | 0.19% | 92 |
|
|
2024
Q3 | $3.16M | Buy |
3,564
+125
| +4% | +$112K | 0.24% | 84 |
|
|
2024
Q2 | $3.11M | Buy |
3,439
+354
| +11% | +$283K | 0.25% | 88 |
|
|
2024
Q1 | $2.4M | Buy |
3,085
+244
| +9% | +$174K | 0.2% | 94 |
|
|
2023
Q4 | $1.66M | Buy |
2,841
+539
| +23% | +$315K | 0.15% | 111 |
|
|
2023
Q3 | $1.24M | Buy |
2,302
+1,271
| +123% | +$655K | 0.12% | 119 |
|
|
2023
Q2 | $484K | Sell |
1,031
-631
| -38% | -$265K | 0.04% | 189 |
|
|
2023
Q1 | $571K | Sell |
1,662
-214
| -11% | -$72.2K | 0.05% | 187 |
|
|
2022
Q4 | $686K | Sell |
1,876
-26
| -1% | -$9.22K | 0.06% | 165 |
|
|
2022
Q3 | $615K | Sell |
1,902
-1,660
| -47% | -$526K | 0.06% | 160 |
|
|
2022
Q2 | $1.16M | Sell |
3,562
-17
| -0.5% | -$5.1K | 0.1% | 128 |
|
|
2022
Q1 | $1.02M | Sell |
3,579
-20
| -0.6% | -$5.15K | 0.08% | 147 |
|
|
2021
Q4 | $995K | Buy |
3,599
+20
| +0.6% | +$5.07K | 0.08% | 144 |
|
|
2021
Q3 | $827K | Sell |
3,579
-100
| -3% | -$24.7K | 0.07% | 150 |
|
|
2021
Q2 | $844K | Sell |
3,679
-604
| -14% | -$121K | 0.07% | 153 |
|
|
2021
Q1 | $800K | Buy |
4,283
+564
| +15% | +$110K | 0.07% | 154 |
|
|
2020
Q4 | $628K | Sell |
3,719
-85
| -2% | -$12.7K | 0.06% | 161 |
|
|
2020
Q3 | $563K | Sell |
3,804
-912
| -19% | -$141K | 0.06% | 159 |
|
|
2020
Q2 | $774K | Buy |
4,716
+1,993
| +73% | +$306K | 0.08% | 132 |
|
|
2020
Q1 | $378K | Sell |
2,723
-54
| -2% | -$7.42K | 0.05% | 168 |
|
|
2019
Q4 | $365K | Sell |
2,777
-25
| -0.9% | -$2.9K | 0.03% | 189 |
|
|
2019
Q3 | $314K | Sell |
2,802
-3,211
| -53% | -$357K | 0.03% | 194 |
|
|
2019
Q2 | $666K | Sell |
6,013
-891
| -13% | -$105K | 0.07% | 141 |
|
|
2019
Q1 | $896K | Buy |
6,904
+350
| +5% | +$42.6K | 0.09% | 121 |
|
|
2018
Q4 | $759K | Sell |
6,554
-2,300
| -26% | -$257K | 0.09% | 124 |
|
|
2018
Q3 | $951K | Sell |
8,854
-1,100
| -11% | -$110K | 0.1% | 128 |
|
|
2018
Q2 | $849K | Sell |
9,954
-697
| -7% | -$57.2K | 0.1% | 132 |
|
|
2018
Q1 | $824K | Sell |
10,651
-2,141
| -17% | -$172K | 0.09% | 133 |
|
|
2017
Q4 | $1.08M | Sell |
12,792
-450
| -3% | -$38.3K | 0.12% | 127 |
|
|
2017
Q3 | $1.13M | Sell |
13,242
-872
| -6% | -$71.5K | 0.13% | 121 |
|
|
2017
Q2 | $1.16M | Sell |
14,114
-235
| -2% | -$19.2K | 0.14% | 123 |
|
|
2017
Q1 | $1.21M | Sell |
14,349
-2,711
| -16% | -$217K | 0.15% | 121 |
|
|
2016
Q4 | $1.25M | Buy |
17,060
+2,544
| +18% | +$189K | 0.17% | 116 |
|
|
2016
Q3 | $1.17M | Buy |
14,516
+700
| +5% | +$56K | 0.14% | 129 |
|
|
2016
Q2 | $1.09M | Buy |
13,816
+850
| +7% | +$64K | 0.14% | 128 |
|
|
2016
Q1 | $934K | Sell |
12,966
-2,075
| -14% | -$157K | 0.13% | 134 |
|
|
2015
Q4 | $1.27M | Sell |
15,041
-1,735
| -10% | -$144K | 0.17% | 114 |
|
|
2015
Q3 | $1.4M | Sell |
16,776
-1,550
| -8% | -$131K | 0.2% | 110 |
|
|
2015
Q2 | $1.53M | Sell |
18,326
-5
| -0% | -$381 | 0.2% | 106 |
|
|
2015
Q1 | $1.33M | Buy |
18,331
+780
| +4% | +$55.5K | 0.18% | 123 |
|
|
2014
Q4 | $1.21M | Sell |
17,551
-1,920
| -10% | -$130K | 0.17% | 131 |
|
|
2014
Q3 | $1.26M | Buy |
19,471
+661
| +4% | +$41.9K | 0.18% | 124 |
|
|
2014
Q2 | $1.17M | Buy |
18,810
+536
| +3% | +$32K | 0.13% | 139 |
|
|
2014
Q1 | $1.08M | Sell |
18,274
-225
| -1% | -$12.6K | 0.12% | 140 |
|
|
2013
Q4 | $943K | Sell |
18,499
-1,526
| -8% | -$76.4K | 0.11% | 159 |
|
|
2013
Q3 | $1.01M | Buy |
20,025
+60
| +0.3% | +$3.14K | 0.13% | 131 |
|
|
2013
Q2 | $981K | Buy |
+19,965
| New | +$1.09M | 0.13% | 130 |
|
Other funds holding LLY
VCM
VPM
Trustmark National Bank Trust Department's LLY Position: Q1 2026 in Review
Trustmark National Bank Trust Department increased its Eli Lilly (LLY) stake by 0.52% in Q1 2026, buying an estimated $22.3K and bringing the position to 4,246 shares worth $3.91M. The position accounts for 0.25% of the portfolio, ranked #78.
Trustmark National Bank Trust Department first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.54M in Q4 2025. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Trustmark National Bank Trust Department held 4,246 shares of Eli Lilly worth $3.91M as of Q1 2026.
- Trustmark National Bank Trust Department bought 22 Eli Lilly shares in Q1 2026, an estimated $22.3K.
- Eli Lilly made up 0.25% of Trustmark National Bank Trust Department's portfolio in Q1 2026, its #78 holding.
- Trustmark National Bank Trust Department first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Trustmark National Bank Trust Department's Eli Lilly position peaked at $4.54M in Q4 2025.
- 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Trustmark National Bank Trust Department's 13F filing for Q1 2026, filed 14 May 2026.